4.6 Review

p53 post-translational modification: deregulated in tumorigenesis

Journal

TRENDS IN MOLECULAR MEDICINE
Volume 16, Issue 11, Pages 528-536

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2010.09.002

Keywords

-

Funding

  1. NCI NIH HHS [R01 CA129627, R01 CA131439, R01 CA118561, P01 CA080058, R01 CA085533, P01 CA097403] Funding Source: Medline

Ask authors/readers for more resources

The p53 tumor suppressor protein has well-established roles in monitoring various types of stress signals by activating specific transcriptional targets that control cell cycle arrest and apoptosis, although some activities are also mediated in a transcription-independent manner. Here, we review the recent advances in our understanding of the wide spectrum of post-translational modifications that act as epigenetic-like codes for modulating specific functions of p53 in vivo and how deregulation of these modifications might contribute to tumorigenesis. We also discuss future research priorities to further understand p53 post-translational modifications and the interpretation of genetic data in appreciation of the increasing evidence that p53 regulates cellular metabolism, autophagy and many unconventional tumor suppressor activities.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available